Department of Radiation Oncology, The University of Texas M. D. Anderson Cancer Center, Houston, TX 77030, USA.
Am J Clin Oncol. 2010 Apr;33(2):173-5. doi: 10.1097/COC.0b013e3181a31c1a.
The purpose of this study was to evaluate the volumetric changes of the prostate and seminal vesicles (SV) during a definitive course of intensity-modulated radiation therapy using a combined computed tomography (CT)-linear accelerator system.
Fifteen patients were enrolled in this IRB-approved prospective study. The treatment plan was designed to deliver a total dose of 75.6 Gy over 42 fractions to 98% of the planning target volume. In-room CT scans were acquired using a CT-on-rails system 3 times weekly just before daily treatment throughout the course of radiation therapy. Rates of volume change over time for the prostate and SV were calculated using linear regression analysis.
Fifteen patients had a total of 369 CT scans during the study. For 53% of patients (N = 8), there was a statistically significant decrease in prostate volume over time (range, 0.05-0.47 mL/d or 0.7%-3.5% per week). The median volume reduction was -11.5% (4.9 mL) at the end of the treatment. There was no significant change in the volume of the SV during the course of treatment. The decrease in prostate volume was significantly correlated with the initial volume of the prostate, with larger glands shrinking more during treatment (P = 0.001).
Patients with enlarged prostates may experience volumetric reduction in their gland size during a protracted course of radiation therapy. However, the magnitude of the volume reduction is relatively small. In the current era of dose escalation, future studies with adaptive radiation therapy strategy may be appropriate to minimize radiation exposure to normal tissues.
本研究旨在评估使用 CT 直线加速器联合系统进行调强放疗过程中前列腺和精囊(SV)的体积变化。
本研究为经机构审查委员会批准的前瞻性研究,共纳入 15 例患者。治疗计划设计为在 42 个分次中给予 75.6Gy 总剂量,使 98%的计划靶区接受照射。在放疗过程中,每周 3 次在治疗前使用 CT-on-rails 系统进行室内 CT 扫描。使用线性回归分析计算前列腺和 SV 随时间的体积变化率。
本研究共进行了 369 次 CT 扫描,15 例患者中,53%(N=8)的前列腺体积随时间呈统计学显著减小(范围为 0.05-0.47mL/d 或每周 0.7%-3.5%)。治疗结束时,前列腺体积中位数减少了-11.5%(4.9mL)。治疗过程中 SV 体积无明显变化。前列腺体积的减少与前列腺的初始体积显著相关,较大的腺体在治疗过程中收缩更多(P=0.001)。
在长时间的放射治疗过程中,前列腺体积较大的患者可能会经历腺体体积缩小。然而,体积减少的幅度相对较小。在当前剂量递增的时代,未来采用自适应放疗策略的研究可能有助于最大限度地减少对正常组织的辐射暴露。